Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial.

Christine NavarroCindy LauSarah A BuchanAnn N BurchellSharifa NasreenLindsay FriedmanEvaezi OkpokoroPeter C AustinDarrell H S TanJonathan B GubbayJeffrey C KwongSharmistha Mishranull null

Published in: BMJ (Clinical research ed.) (2024)

The findings of this study, conducted in the context of a targeted vaccination programme and evolving outbreak of mpox, suggest that one dose of MVA-BN is moderately effective in preventing mpox infection.

Keyphrases

study protocol
randomized controlled trial
systematic review
clinical trial
phase iii
phase ii